ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 195,97
0,35%
Dow Jones
39 806,77
-0,49%
DAX
18 768,96
0,33%
Brent Oil
83,485
-0,13%
Bitcoin
69 170,81
4,37%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Telomir Pharmaceuticals Inc (TELO)

  7. Telomir Pharmaceuticals Inc (TELO) Actualités

TELO

Telomir Pharmaceuticals (TELO)

Telomir Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TELO
DateHeureSourceTitreSymboleSociété
16/05/202415h30GlobeNewswire Inc.Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial SupportNASDAQ:TELOTelomir Pharmaceuticals Inc
13/05/202422h31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TELOTelomir Pharmaceuticals Inc
16/04/202414h30GlobeNewswire Inc.Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.NASDAQ:TELOTelomir Pharmaceuticals Inc
02/04/202414h30GlobeNewswire Inc.Telomir Pharmaceuticals’ Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024NASDAQ:TELOTelomir Pharmaceuticals Inc
29/03/202421h44GlobeNewswire Inc.UPDATE – Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in CaninesNASDAQ:TELOTelomir Pharmaceuticals Inc
26/03/202413h30GlobeNewswire Inc.Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in CaninesNASDAQ:TELOTelomir Pharmaceuticals Inc
22/03/202413h30GlobeNewswire Inc.Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26thNASDAQ:TELOTelomir Pharmaceuticals Inc
14/03/202413h30GlobeNewswire Inc.Telomir Pharmaceuticals Uses AI Testing Models to Show its Lead Product Candidate’s Potential in DNA Age Reversal ScienceNASDAQ:TELOTelomir Pharmaceuticals Inc
07/03/202414h30GlobeNewswire Inc.Telomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore ConferenceNASDAQ:TELOTelomir Pharmaceuticals Inc
05/03/202414h30GlobeNewswire Inc.Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age ReversalNASDAQ:TELOTelomir Pharmaceuticals Inc
13/02/202422h05GlobeNewswire Inc.Telomir Pharmaceuticals Announces Closing of Initial Public OfferingNASDAQ:TELOTelomir Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TELO

Dernières Valeurs Consultées

TSX
PSU.U
Purpose US Cash
POLO
MESSIUSDT
MESSI COIN
TG
A3MP61
Dz Hyp
BIT
I09321
Intesa Sanpaolo
ASX
THROD
Thor Energy
KOSPI
003530
Hanwha Investment and Se...
BIT
I09319
Intesa Sanpaolo
TG
MS8KKB
Morgan Stanley
EU
FR0128075068
CA Consumer Finance Cacf...
COIN
STDUST
STEED
USOTC
DVHGF
Devonian Health (QB)
USOTC
KGLDD
King Global Ventures (PK)
LSE
XCNA
X Cna A Esgscr
USOTC
IVEUF
Invesco Markets PLC Inve... (PK)
BIT
P1U8N3
NLBNPIT1U8N3 20240621 38
COIN
ZENFETH
ZENF Token
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés